Fixed hospital payments put device budgets under renewed pressure

Diagnosis-related group payments set the revenue side of most European hospital budgets. When tariffs are not indexed to the cost of devices, consumables, and staff, the difference is absorbed by the hospital, and capital replacement is usually the first item deferred. The pattern is not uniform: systems with separate investment funding have weathered the period better than those that fund equipment from operating revenue.

Suppliers describe a consistent pattern in such markets: imaging and surgical systems that would normally be replaced on a seven-year cycle are kept in service longer, with refurbishment and extended service contracts filling the gap. Consumable volumes hold up better, because they follow clinical activity rather than capital planning, and because a shortage of consumables stops work immediately rather than gradually.

The pressure also reaches pricing negotiations. Hospitals ask for multi-year price stability and for bundled service, while suppliers face their own input cost increases. The compromise often lands on a lower capital price with a longer, more comprehensive service agreement attached, which shifts spending from the investment budget to the operating budget and makes the purchase easier to approve internally.

Health economists note that deferral has a real cost. Older equipment tends to have higher downtime, less efficient dose performance, and fewer interoperability features, and the eventual replacement becomes more urgent and less negotiable. The savings recorded in one budget year frequently reappear as a larger capital request two years later, usually accompanied by a clinical case built on service interruptions.